Adults who regularly consume high amounts of artificial sweeteners experience accelerated cognitive decline equivalent to aging 1.6 years faster than those with minimal intake, according to new research. The effect proves strongest in people under 60 and those with diabetes.
The study tracked cognitive function across multiple groups, measuring memory and thinking speed alongside sweetener consumption. Participants with the highest intake showed substantially steeper declines in these measures compared to low consumers. The effect size raises questions about the safety profile these products maintain in regulatory reviews and consumer perception.
Artificial sweeteners like aspartame, sucralose, and saccharin have faced periodic scrutiny since their introduction. Manufacturers promote them as alternatives to sugar for weight management and blood glucose control. Yet this research suggests potential neurological consequences that offset metabolic benefits. The mechanism remains unclear. Researchers propose several pathways: sweeteners may trigger inflammatory responses in the brain, disrupt the gut microbiome in ways that affect cognition, or alter glucose metabolism independently of their sweetness.
The findings warrant caution, though researchers emphasized their limitations. This observational study cannot prove causation. People consuming high sweetener amounts may differ in other health behaviors, diet quality, or baseline health status that drive cognitive decline. Reverse causation is also possible, where early cognitive changes prompt people to shift toward artificial sweeteners. The research requires replication in controlled trials before drawing firm conclusions about sweetener safety.
The study's demographic specificity matters. The pronounced effect in adults under 60 challenges assumptions about aging and risk. Younger brains may be more vulnerable to whatever mechanism artificial sweeteners trigger. Those with diabetes showed exaggerated effects, suggesting metabolic status influences susceptibility.
Public health agencies including the FDA and WHO maintain that approved sweeteners are safe at current consumption levels. This research introduces friction into that consensus. It does not overturn existing safety determinations but identifies a potential adverse effect